Staas; Jay K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Staas; Jay K..The latest application filed is for "methods of inducing melanogenesis in a subject".

Company Profile

0.17.6

Staas; Jay K. - Maylene AL
Staas; Jay K. - Marylene AL
Staas; Jay K. - Madison AL
Staas; Jay K. - Alabaster AL
Staas; Jay K. - Pelham AL
Staas; Jay K. - Birmingham AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of inducing melanogenesis in a subject Grant 10,857,208 - Kleinig , et al. December 8, 2	2020-12-08
Methods Of Inducing Melanogenesis In A Subject App 20180360919 - KLEINIG; Michael John ; et al.	2018-12-20
Methods of inducing melanogenesis in a subject Grant 10,076,555 - Kleinig , et al. September 18, 2	2018-09-18
Methods Of Inducing Melanogenesis In A Subject App 20160235819 - KLEINIG; Michael John ; et al.	2016-08-18
Methods of inducing melanogenesis in a subject Grant 9,345,911 - Kleinig , et al. May 24, 2	2016-05-24
Methods for Manufacturing Delivery Systems and Systems Thereof App 20140037707 - Staas; Jay K. ; et al.	2014-02-06
Methods for manufacturing delivery devices and devices thereof Grant 8,541,028 - Staas , et al. September 24, 2	2013-09-24
Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances Grant 7,473,431 - Tice , et al. January 6, 2	2009-01-06
Methods of Inducing Melanogenesis in a Subject App 20080305152 - Kleinig; Michael John ; et al.	2008-12-11
Reduced-mass, long-acting dosage forms App 20080305115 - Tice; Thomas R. ; et al.	2008-12-11
Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances App 20030152638 - Tice, Thomas R. ; et al.	2003-08-14
Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances Grant 6,495,155 - Tice , et al. December 17, 2	2002-12-17
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof Grant 6,312,731 - Staas , et al. November 6, 2	2001-11-06
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol Grant 6,306,425 - Tice , et al. October 23, 2	2001-10-23
Composition for delivering bioactive agents for immune response and its preparation Grant 6,024,983 - Tice , et al. February 15, 2	2000-02-15
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release Grant 5,942,252 - Tice , et al. August 24, 1	1999-08-24
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release Grant 5,853,763 - Tice , et al. December 29, 1	1998-12-29
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release Grant 5,820,883 - Tice , et al. October 13, 1	1998-10-13
Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release Grant 5,814,344 - Tice , et al. September 29, 1	1998-09-29
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor Grant 5,811,128 - Tice , et al. September 22, 1	1998-09-22
Method of potentiating an immune response Grant 5,075,109 - Tice , et al. December 24, 1	1991-12-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.